HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing In Brief

This article was originally published in The Rose Sheet

Executive Summary

StriVectin-SD: Eye cream ($59) is formulated with the same functional ingredients as original blockbuster anti-aging treatment as well as soothing agents developed for the sensitive eye area, but lacks aromatic oils, such as peppermint, which may cause irritation, Klein-Becker says. Eye cream lightens dark circles while reducing the appearance of fine lines, wrinkles and crow's feet like the original formula, firm claims. StriVectin eye treatment debuted in Parisian stores earlier this summer, and currently is available in the brand's full distribution, including department and specialty stores such as Sephora, Bloomingdale's and Macy's...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel